Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Peter Richard Roth has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 10, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13718720

METHOD OF TREATING GASTROINTESTINAL STROMAL TUMORS

IPC classification:
A61K 31/506, A61K 31/4709, A61P 35/00
Applicant:
Novartis AG
Agent:
Peter Richard Roth, Novartis Pharma AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature